The store will not work correctly when cookies are disabled.
1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
ID: ALA4876796
Cas Number: 640287-98-5
PubChem CID: 12114412
Max Phase: Preclinical
Molecular Formula: C12H10F3N3O2
Molecular Weight: 285.23
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: NCc1cccc(-n2nc(C(F)(F)F)cc2C(=O)O)c1
Standard InChI: InChI=1S/C12H10F3N3O2/c13-12(14,15)10-5-9(11(19)20)18(17-10)8-3-1-2-7(4-8)6-16/h1-5H,6,16H2,(H,19,20)
Standard InChI Key: AMUXDCKKFCHHLY-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
14.5058 -4.8536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5046 -5.6731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2127 -6.0821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9224 -5.6726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9195 -4.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2109 -4.4447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6307 -6.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3378 -5.6704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2085 -3.6275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8623 -3.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6074 -2.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7902 -2.3703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5401 -3.1483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3078 -1.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6379 -0.9631 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.4954 -1.7986 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.7230 -1.1267 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.6409 -3.3925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8152 -4.1909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2451 -2.8423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
6 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
12 14 1 0
14 15 1 0
14 16 1 0
14 17 1 0
10 18 1 0
18 19 2 0
18 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 285.23 | Molecular Weight (Monoisotopic): 285.0725 | AlogP: 2.05 | #Rotatable Bonds: 3 |
Polar Surface Area: 81.14 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.38 | CX Basic pKa: 9.27 | CX LogP: -0.24 | CX LogD: -0.24 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.90 | Np Likeness Score: -1.38 |
References
1. Kotian PL, Wu M, Vadlakonda S, Chintareddy V, Lu P, Juarez L, Kellogg-Yelder D, Chen X, Muppa S, Chambers-Wilson R, Davis Parker C, Williams J, Polach KJ, Zhang W, Raman K, Babu YS.. (2021) Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)., 64 (17.0): [PMID:34436898] [10.1021/acs.jmedchem.1c00511] |